PROVIDER PROFILE · NPI 1598974891

Rahfa Kurdi ZeriklyMD

PRACTICEMAINEHEALTHSee all providers at this practice →

EndocrinologyScarborough, MEI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

365

Unique beneficiaries

—

Total services

417

Distinct HCPCS

Medicare payment

$17K

Peer benchmark

Total Medicare services vs. 22 Endocrinology providers in ME — above median (cohort median 280).

PRESCRIBING · PART D · 2024

Total Rx claims

1,739

Beneficiaries

—

Total drug cost

$719K

Distinct drugs

Brand share

63.3%

Top prescribed drugs

Levothyroxine Sodium305 claims

Levothyroxine Sodium147 claims

Metformin Hcl146 claims

Methimazole87 claims

Glipizide84 claims

QUALITY · MIPS · 2024

Final MIPS score

97.9

Quality

83.3

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.97%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Rahfa Kurdi Zerikly's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MAINEHEALTH	211	631
Nordx Clinical Laboratory · Scarborough, ME	54	226
D'ANGELO-COOLEY, SUSANNE	13	29
MARTINS POINT HEALTHCARE	11	30

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history